Analytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.

Author： Trows Sabrina   Wuchner Klaus   Spycher Rene   Steckel Hartwig  

Publisher： MDPI

E-ISSN： 1999-4923|6|2|195-219

ISSN： 1999-4923

Source： Pharmaceutics, Vol.6, Iss.2, 2014-04, pp. : 195-219

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Eluting Nasal Implants: Formulation, Characterization, Clinical Applications and Challenges

By Parikh Ankit   Anand Utkarshini   Ugwu Malachy C.   Feridooni Tiam   Massoud Emad   Agu Remigius U.  

Pharmaceutics, Vol. 6, Iss. 2, 2014-05 ,pp. : 249-267

MDPI

Access to resources Recommend Favorite

On the Regulatory Approval Pathway of Biosimilar Products

By Wang Jun   Chow Shein-Chung  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-03 ,pp. : 353-368

MDPI

Access to resources Recommend Favorite

Non-Native (Exotic) Snake Envenomations in the U.S., 2005–2011

By Warrick Brandon J.   Boyer Leslie V.   Seifert Steven A.  

Toxins, Vol. 6, Iss. 10, 2014-09 ,pp. : 2899-2911

MDPI

Access to resources Recommend Favorite

Drug Development for Pediatric Populations: Regulatory Aspects

By Zisowsky Jochen   Krause Andreas   Dingemanse Jasper  

Pharmaceutics, Vol. 2, Iss. 4, 2010-11 ,pp. : 364-388

MDPI

Access to resources Recommend Favorite

Biomarker Analysis of Stored Blood Products: Emphasis on Pre-Analytical Issues

By Delobel Julien   Rubin Olivier   Prudent Michel   Crettaz David   Tissot Jean-Daniel   Lion Niels  

International Journal of Molecular Sciences, Vol. 11, Iss. 11, 2010-11 ,pp. : 4601-4617

MDPI

Access to resources Recommend Favorite